| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/25/1992 | WO1992010509A1 Renin-inhibiting peptides of the cyclohexylstatin type, process for producing the same and their use in medicaments |
| 06/25/1992 | WO1992006992A3 New process for biophosphorylating organic compounds |
| 06/25/1992 | DE4042008A1 Vasopressin-derivate Vasopressin derivatives |
| 06/25/1992 | CA2057675A1 Peptide inhibitors of ras-gap interaction |
| 06/24/1992 | EP0491675A1 Improvements relating to growth factors |
| 06/24/1992 | EP0491628A2 Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines |
| 06/24/1992 | EP0491361A2 Short peptides having the effect of insulin |
| 06/23/1992 | US5124478 Acid-labile anchor groups for the synthesis of peptide amides by a solid-phase method |
| 06/22/1992 | WO1992011021A1 Angiogenic peptides |
| 06/22/1992 | CA2058168A1 New use of peptide derivative |
| 06/22/1992 | CA2035810A1 Enrichment of delta-bilipeptides solutions |
| 06/22/1992 | CA2035809A1 Bilipeptides and processes for their preparation |
| 06/17/1992 | EP0490667A2 HIV protease inhibitors |
| 06/17/1992 | EP0490383A2 Peptides of the HIV-gag protein, their preparation and use |
| 06/17/1992 | EP0489968A1 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 06/17/1992 | EP0357637B1 General cancer-associated scm-recognition factor, preparation and method of use |
| 06/17/1992 | DE4039589A1 New hydroxy-acyl deca:peptide derivs. - are antiproliferative and antiinflammatory agents used to treat e.g. dermatitis |
| 06/16/1992 | US5122610 Renin inhibitor intermediates |
| 06/16/1992 | US5122511 Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| 06/16/1992 | CA1303627C Nona and decapeptide analogs of lhrh useful as lhrh antagonists |
| 06/16/1992 | CA1303532C Determination of fibrin using fibrin-specific antibodies |
| 06/11/1992 | WO1992009628A1 Synthetic immunoactive peptides having immunomodulating and therapeutic activities |
| 06/11/1992 | WO1992009626A1 Nonapeptide bombesin antagonists |
| 06/11/1992 | WO1992009617A1 Cell stress transcriptional factors |
| 06/11/1992 | WO1992009300A1 Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures |
| 06/11/1992 | WO1992009297A1 Hiv protease inhibitors |
| 06/11/1992 | WO1992009296A1 A peptide which regulates weight gain in mammals |
| 06/11/1992 | DE4038947A1 Dithiolano- und dithianoglycin-haltige renininhibitorische peptide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Dithiolano- and dithianoglycin-containing peptide renininhibitorische, process for their production and their use in medicinal products |
| 06/11/1992 | DE4038921A1 Renininhibitorische peptide vom cyclohexylstatin-typ, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Renininhibitorische peptide from cyclohexylstatin-type, process for their production and their use in medicinal products |
| 06/10/1992 | EP0489332A1 Microcarrier for anchorage-dependent cells |
| 06/10/1992 | EP0489220A1 Cytotoxic N,N'-bis (succinyl-peptide-) derivatives of 1,4-bis (aminoalkyl)-5,8-dihydroxyanthraquinones and antibody conjugates thereof |
| 06/10/1992 | CN1016967B Process for purifying human physiologically active polypeptide |
| 06/09/1992 | US5120859 Chimeric amino acid analogues |
| 06/09/1992 | US5120831 Metal-peptide compositions |
| 06/09/1992 | US5120830 Anticoagulant |
| 06/09/1992 | US5120829 Hydrophobic attachment site for adhesion peptides |
| 06/09/1992 | US5120644 Reacting enzyme with substrate containing fluorescent substituent |
| 06/09/1992 | US5120639 Neutralizing herpes simplex virus DNA polymerase using an antibody obtained from a specified decapeptide and measuring amount of bound antibody |
| 06/09/1992 | CA1303292C Anhydrous enhanced coupling |
| 06/07/1992 | WO1992010092A1 Very large scale immobilized polymer synthesis |
| 06/07/1992 | CA2097708A1 Very large scale immobilized polymer synthesis |
| 06/06/1992 | WO1992010516A1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them |
| 06/06/1992 | CA2095725A1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics and a process for preparing them |
| 06/03/1992 | EP0488979A1 Novel inhibitory peptides |
| 06/03/1992 | EP0487629A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/03/1992 | EP0474789A4 Cysteine thiol-protected peptides for use in immunoassays |
| 06/03/1992 | CN1061606A Polypeptide compounds having growth hormone releasing activity |
| 06/03/1992 | CN1061605A Synthesis, products and its application for luteinizing hormone releasing hormone and antagonistic analogue |
| 06/02/1992 | US5118669 Peptides and intermediates therefor useful as antiallergic agents, vasodilators and immunoregulators |
| 06/02/1992 | US5118665 Enhance or restore resistance of mammals to damage caused by release of reactive oxygen species |
| 06/02/1992 | CA1302650C Gnrh antagonists viii |
| 05/31/1992 | WO1992009620A1 Solution phase process for synthesis of peptide |
| 05/31/1992 | CA2097305A1 Solution phase process for synthesis of peptide |
| 05/29/1992 | WO1992008733A1 Lhrh-antagonists |
| 05/29/1992 | WO1992008732A1 Synthetic peptide producing antibodies to ldh-c¿4? |
| 05/29/1992 | WO1992008487A1 Recombinant feline coronavirus s proteins |
| 05/27/1992 | EP0487410A2 Endothelin antagonists |
| 05/27/1992 | EP0487289A2 Cyclosporin immunoassay |
| 05/27/1992 | EP0486861A1 Active fragments of fibroblast growth factor |
| 05/27/1992 | EP0486622A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/27/1992 | CN1016795B Production of hemopoietin |
| 05/26/1992 | US5116952 Protein active in humoral hypercalcemia of malignancy-pthrp |
| 05/26/1992 | US5116948 Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 05/26/1992 | CA1301677C Recombinant surface antigens of swine mycoplasma and vaccines and diagnostics based on them |
| 05/24/1992 | CA2055961A1 Active fragments of fibroblast growth factor |
| 05/22/1992 | CA2055902A1 Peptide derivatives, their preparation process, application of these new derivatives as drugs and pharmaceutical compositions containing them |
| 05/21/1992 | CA2055813A1 Cyclosporin immunoassay |
| 05/20/1992 | EP0486478A2 Renin-inhibiting peptides |
| 05/20/1992 | EP0486011A2 Pharmaceutical composition against Pneumocystis carinii |
| 05/20/1992 | EP0437556A4 Substitution analogues of magainin peptides |
| 05/19/1992 | US5115098 End-blocked peptides inhibiting binding capacity of gp120 |
| 05/19/1992 | US5115097 Synthetic peptide from the carboxy terminal of human Mn-superoxide dismutase |
| 05/19/1992 | US5114926 Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses |
| 05/19/1992 | US5114921 Amphiphilic peptides and use thereof |
| 05/19/1992 | US5114920 BU-3292T antibiotics |
| 05/19/1992 | US5114918 Endothelin antagonistic cyclic pentapeptides |
| 05/19/1992 | US5114713 P. falciparum cs-peptides as universal t-cell epitope |
| 05/19/1992 | US5114413 Methods to make and use proteinaceous material present in kinin-free high molecular weight kininogen |
| 05/14/1992 | WO1992007874A1 Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence |
| 05/14/1992 | WO1992007871A1 Peptide-based inhibitors of hiv replication |
| 05/14/1992 | WO1992007869A1 Inhibitors and substrates of thrombin |
| 05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/1992 | CA2092075A1 Peptide-based inhibitors of hiv replication |
| 05/13/1992 | EP0485361A1 Pre-S gene codes peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 05/13/1992 | EP0484787A2 HCV-specific peptides, process for obtaining them and their use |
| 05/13/1992 | EP0484719A2 Tachykinin antagonist |
| 05/12/1992 | US5112947 Oligopeptides, nootropic agents |
| 05/12/1992 | US5112946 Polypeptides and proteins with mutant segments for treatment of cardiovascular disorders and antitumor agents |
| 05/12/1992 | US5112945 Preparation of islet amyloid polypeptides (iapp) and antibodies to iapp |
| 05/12/1992 | US5112811 Sdk peptides and therapeutic compositions containing them |
| 05/12/1992 | US5112806 Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical |
| 05/12/1992 | US5112596 A composition of a neuropharmaceutical or diagnostic agent, a bradykinin agonist to increase blood brain barrier permeability |
| 05/12/1992 | CA1300807C Heterocyclic derivatives |
| 05/12/1992 | CA1300536C Process for antifungal fermentation product and culture |
| 05/06/1992 | EP0484281A2 Cyclosporins |
| 05/06/1992 | EP0483961A1 Specific binding agents |
| 05/05/1992 | USH1056 Luteinizing hormone-releasing hormone |
| 05/05/1992 | US5110904 Lhrh analogs |
| 05/03/1992 | WO1992007870A1 Platelet aggregation inhibitors |
| 05/03/1992 | CA2092315A1 Platelet aggregation inhibitors |